- Home
- MGTX vs TCPC Comparison
MGTX vs TCPC Comparison
Compare MGTX & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- TCPC
- Stock Information
- Founded
- MGTX 2015
- TCPC 2006
- Country
- MGTX United States
- TCPC United States
- Employees
- MGTX N/A
- TCPC N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- TCPC Finance/Investors Services
- Sector
- MGTX Health Care
- TCPC Finance
- Exchange
- MGTX Nasdaq
- TCPC Nasdaq
- Market Cap
- MGTX 670.2M
- TCPC 665.8M
- IPO Year
- MGTX N/A
- TCPC 2012
- Fundamental
- Price
- MGTX $7.83
- TCPC $7.08
- Analyst Decision
- MGTX Strong Buy
- TCPC Sell
- Analyst Count
- MGTX 2
- TCPC 2
- Target Price
- MGTX $24.00
- TCPC $6.75
- AVG Volume (30 Days)
- MGTX 522.1K
- TCPC 555.7K
- Earning Date
- MGTX 08-14-2025
- TCPC 08-07-2025
- Dividend Yield
- MGTX N/A
- TCPC 17.23%
- EPS Growth
- MGTX N/A
- TCPC N/A
- EPS
- MGTX N/A
- TCPC N/A
- Revenue
- MGTX $37,917,000.00
- TCPC $239,535,768.00
- Revenue This Year
- MGTX $145.67
- TCPC N/A
- Revenue Next Year
- MGTX $167.61
- TCPC N/A
- P/E Ratio
- MGTX N/A
- TCPC N/A
- Revenue Growth
- MGTX 366.84
- TCPC 3.11
- 52 Week Low
- MGTX $3.85
- TCPC $6.27
- 52 Week High
- MGTX $8.98
- TCPC $9.72
- Technical
- Relative Strength Index (RSI)
- MGTX 49.11
- TCPC 41.61
- Support Level
- MGTX $7.43
- TCPC $7.02
- Resistance Level
- MGTX $8.63
- TCPC $7.20
- Average True Range (ATR)
- MGTX 0.45
- TCPC 0.15
- MACD
- MGTX -0.06
- TCPC 0.02
- Stochastic Oscillator
- MGTX 40.89
- TCPC 60.00
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About TCPC BlackRock TCP Capital Corp.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.